Medtronic, Parkinson's and FDA

FDA approves Medtronic’s brain stimulation system for Parkinson’s
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
US FDA approves Medtronic's medical device for Parkinson's disease
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with Parkinson's disease, the medical device maker said on Monday.
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy automatically adjusts, which minimizes the need for patients to manually change the level of stimulation to control symptoms.
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the FDA’s approval for its adaptive, closed-loop neurostimulation ap | The company said its U.
Medtronic Parkinson's Disease Brain Stimulation System Gets FDA Approval
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.
Medtronic’s BrainSense brain stimulation system approved by FDA for Parkinson’s
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no
2 Very Healthy High-Yield Dividend Stocks to Buy for a Safe and Growing Passive Income Stream
Medtronic ( MDT 2.27%) and Johnson & Johnson ( JNJ 1.64%) are two very healthy, high-yielding dividend stocks. This makes ...
Medtronic expects pressure in surgical unit for fourth quarter, shares fall
Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...
Medtronic’s stock drops on inventory hiccup and revenue miss
Jeff Jonas, portfolio manager at Gabelli Funds, said he’s surprised at the drop in Medtronic’s stock on the heels of its ...
Why Medtronic Stock Is Sinking Today
Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...
Medtronic's diabetes device sales drive profit beat but surgical unit lags
Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, partly helped by demand for its diabetes devices, ...
Medtronic stock moves lower amid declines in surgical stapler business
The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.
Medtronic PLC stock outperforms competitors on strong trading day
Shares of Medtronic PLC MDT rallied 2.27% to $89.94 Friday, on what proved to be an all-around poor trading session for the ...
Medtronic (NYSE:MDT) Stock Price Up 0.3% Following Analyst Upgrade
Medtronic plc (NYSE:MDT – Get Free Report) shares were up 0.3% on Thursday after UBS Group raised their price target on the stock from $85.00 to $95.00. UBS Group currently has a neutral rating on the ...